Dec. 15, 2021 Price forecast | 2 weeks: 5.81% | 1 month: 3.89% | 3 months: 22.61% | Premium Forecast

VERO stock forecast

Our latest prediction for Venus Concept Inc's stock price was made on the Dec. 15, 2021 when the stock price was at 1.29$.

In the short term (2weeks), VERO's stock price should outperform the market by 5.81%. During that period the price should oscillate between -11.69% and +24.63%.

In the medium term (3months), VERO's stock price should outperform the market by 22.61%. During that period the price should oscillate between -39.07% and +68.87%.

Create a solid portfolio with VERO

Add VERO to your portfolio and optimize it!

About Venus Concept Inc

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic technologies, and reach in over 60 countries and 29 direct markets. Venus Concept focuses its product sale strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, and Venus Bliss. Venus Concept's hair restoration division includes NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX™ Robotic Hair Restoration Systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.

At the moment the company generates 107M USD in revenues.

On its last earning announcement, the company reported a loss of -0.59$ per share.

The book value per share is -0.73$

Venus Concept Inc website

Three months stock forecastDec. 15, 2021


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
107M 67.70% -30M -27.86% -28M -0.59 - - 65M -0.73 - - -